Abstract
Human kallikrein-related peptidase 12 (KLK12) is a new member of the human tissue kallikrein family. Preliminary studies suggest that KLK12 is differentially expressed in breast cancer and may have potential use as a cancer biomarker. It has been predicted that KLK12 is a secreted serine protease. However, the enzymatic properties of this protein have not been reported so far. Here, we report the production of recombinant KLK12 and analyses of its enzymatic characteristics, including zymogen activation, substrate specificity, and regulation of its activity. KLK12 is secreted as an inactive pro-enzyme, which is able to autoactivate to gain enzymatic activity. Through screening of a panel of fluorogenic and chromogenic peptide substrates, we establish that active KLK12 possesses trypsin-like activity, cleaving peptide bonds after both arginine and lysine. Active KLK12 quickly loses its activity due to autodegradation, and its activity can also be rapidly inhibited by zinc ions and by α2-antiplasmin through covalent complex formation. Furthermore, we demonstrate that KLK12 is able to activate KLK11 zymogen in vitro. Our results indicate that KLK12 may participate in enzymatic cascades involving other kallikreins.
References
Bayes, A., Tsetsenis, T., Ventura, S., Vendrell, J., Aviles, F.X., and Sotiropoulou, G. (2004). Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation. Biol. Chem.385, 517–524.10.1515/BC.2004.061Search in Google Scholar PubMed
Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer4, 876–890.10.1038/nrc1474Search in Google Scholar PubMed
Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y., and Egelrud, T. (2005). A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol.124, 198–203.10.1111/j.0022-202X.2004.23547.xSearch in Google Scholar PubMed
Christensson, A., Laurell, C.B., and Lilja, H. (1990). Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem.194, 755–763.10.1111/j.1432-1033.1990.tb19466.xSearch in Google Scholar PubMed
Christensson, A. and Lilja, H. (1994). Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem.220, 45–53.10.1111/j.1432-1033.1994.tb18597.xSearch in Google Scholar PubMed
Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci.41, 265–312.10.1080/10408360490471931Search in Google Scholar PubMed
Cloutier, S.M., Kundig, C., Felber, L.M., Fattah, O.M., Chagas, J.R., Gygi, C.M., Jichlinski, P., Leisinger, H.J., and Deperthes, D. (2004). Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates. Eur. J. Biochem.271, 607–613.10.1111/j.1432-1033.2003.03963.xSearch in Google Scholar PubMed
Diamandis, E.P. and Yousef, G.M. (2002). Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem.48, 1198–1205.10.1093/clinchem/48.8.1198Search in Google Scholar
Felber, L.M., Borgono, C.A., Cloutier, S.M., Kundig, C., Kishi, T., Ribeiro Chagas, J., Jichlinski, P., Gygi, C.M., Leisinger, H.J., Diamandis, E.P., and Deperthes, D. (2005). Enzymatic profiling of human kallikrein 14 using phage-display substrate technology. Biol. Chem.386, 291–298.10.1515/BC.2005.035Search in Google Scholar PubMed
Johnson, G.D. and Jiang, W. (2005). Characterization of cathepsin L secreted by Sf21 insect cells. Arch. Biochem. Biophys.444, 7–14.10.1016/j.abb.2005.09.011Search in Google Scholar PubMed
Harris, J.L., Backes, B.J., Leonetti, F., Mahrus, S., Ellman, J.A., and Craik, C.S. (2000). Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl. Acad. Sci. USA97, 7754–7759.10.1073/pnas.140132697Search in Google Scholar
Kavanagh, J.P. (1985). Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid. J. Reprod. Fertil.75, 35–41.10.1530/jrf.0.0750035Search in Google Scholar
Kraut, H., Frey E.K., and Werle, E. (1930). Der Nachweis eines Kreislaufhormons in der Pankreasdrüse. Hoppe-Seyler's Z. Physiol. Chem.192, 1–21.Search in Google Scholar
Kurlender, L., Borgono, C., Michael, I.P., Obiezu, C., Elliott, M.B., Yousef, G.M., and Diamandis, E.P. (2005). A survey of alternative transcripts of human tissue kallikrein genes. Biochim. Biophys. Acta1755, 1–14.10.1016/j.bbcan.2005.02.001Search in Google Scholar
Lovgren, J., Rajakoski, K., Karp, M., Lundwall, A., and Lilja, H. (1997). Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem. Biophys. Res. Commun.238, 549–555.10.1006/bbrc.1997.7333Search in Google Scholar
Lovgren, J., Airas, K., and Lilja, H. (1999a). Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors. Eur. J. Biochem.262, 781–789.10.1046/j.1432-1327.1999.00433.xSearch in Google Scholar
Lovgren, J., Tian, S., Lundwall, A., Karp, M., and Lilja, H. (1999b). Production and activation of recombinant hK2 with pro-peptide mutations resulting in high expression levels. Eur. J. Biochem.266, 1050–1055.10.1046/j.1432-1327.1999.00946.xSearch in Google Scholar
Lundwall, A., Band, V., Blaber, M., Clements, J.A., Courty, Y., Diamandis, E.P., Fritz, H., Lilja, H., Malm, J., Maltais, L.J., et al. (2006). A comprehensive nomenclature for serine pro-teases with homology to tissue kallikreins. Biol. Chem.387, 637–641.Search in Google Scholar
Luo, L-Y., Shan, S.J.C., Elliott, M.B., Soosaipillai, A., and Diamandis, E.P. (2006). Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma. Clin. Cancer Res.12, 742–750.10.1158/1078-0432.CCR-05-1696Search in Google Scholar
Malm, J., Hellman, J., Hogg, P., and Lilja, H. (2000). Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn2+, a tight-binding inhibitor. Prostate45, 132–139.10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3Search in Google Scholar
Matsumura, M., Bhatt, A.S., Andress, D., Clegg, N., Takayama, T.K., Craik, C.S., and Nelson, P.S. (2005). Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate62, 1–13.10.1002/pros.20101Search in Google Scholar
Matthews, D.J. and Wells, J.A. (1993). Substrate phage: selection of protease substrates by monovalent phage display. Science260, 1113–1117.10.1126/science.8493554Search in Google Scholar
Michael, I.P., Pampalakis, G., Mikolajczyk, S.D., Malm, J., Sotiropoulou, G., and Diamandis, E.P. (2006). Human tissue kallikrein 5 (HK5) is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. J. Biol. Chem.281, 12743–12750.10.1074/jbc.M600326200Search in Google Scholar
Michael, I.P., Sotiropoulou, G., Pampalakis, G., Magklara, A., Ghosh, M., Wasney, G., and Diamandis, E.P. (2005). Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J. Biol. Chem.280, 14628–14635.10.1074/jbc.M408132200Search in Google Scholar
Mikolajczyk, S.D., Millar, L.S., Marker, K.M., Grauer, L.S., Goel, A., Cass, M.M., Kumar, A., and Saedi, M.S. (1997). Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2. Eur. J. Biochem.246, 440–446.10.1111/j.1432-1033.1997.00440.xSearch in Google Scholar
Rittenhouse, H.G., Finlay, J.A., Mikolajczyk, S.D., and Partin, A.W. (1998). Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci.35, 275–368.10.1080/10408369891234219Search in Google Scholar
Salvesen, G.S. and Nagase, H. (2001). Inhibition of proteolytic enzymes. In: Proteolytic Enzymes, R. Beynon, and J.S. Bond, eds. (Oxford, UK: Oxford University Press), pp. 105–147.Search in Google Scholar
Shinmura, K., Tao, H., Yamada, H., Kataoka, H., Sanjar, R., Wang, J., Yoshimura, K., and Sugimura, H. (2004). Splice-site genetic polymorphism of the human kallikrein 12 (KLK12) gene correlates with no substantial expression of KLK12 protein having serine protease activity. Hum. Mutat.24, 273–274.10.1002/humu.9270Search in Google Scholar
Stenman, U.H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K., and Alfthan, O. (1991). A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res.51, 222–226.Search in Google Scholar
Stephenson, S.A., Verity, K., Ashworth, L.K., and Clements, J.A. (1999). Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3–13.4. J. Biol. Chem.274, 23210–23214.10.1074/jbc.274.33.23210Search in Google Scholar
Takayama, T.K., Carter, C.A., and Deng, T. (2001a). Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by de-generate PCR. Biochemistry40, 1679–1687.10.1021/bi002129rSearch in Google Scholar
Takayama, T.K., McMullen, B.A., Nelson, P.S., Matsumura, M., and Fujikawa, K. (2001b). Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Biochemistry40, 15341–15348.10.1021/bi015775eSearch in Google Scholar
Vaisanen, V., Lovgren, J., Hellman, J., Piironen, T., Lilja, H., and Pettersson, K. (1999). Characterization and processing of prostate-specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells. Prostate Cancer Prostat. Dis.2, 91–97.10.1038/sj.pcan.4500289Search in Google Scholar
Yoshida, S., Taniguchi, M., Suemoto, T., Oka, T., He, X., and Shiosaka, S. (1998). cDNA cloning and expression of a novel serine protease, TLSP. Biochim. Biophys. Acta1399, 225–228.10.1016/S0167-4781(98)00116-XSearch in Google Scholar
Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev.22, 184–204.Search in Google Scholar
Yousef, G.M. and Diamandis, E.P. (2002). Human tissue kallikreins: a new enzymatic cascade pathway? Biol. Chem.383, 1045–1057.10.1515/BC.2002.113Search in Google Scholar PubMed
Yousef, G.M., Chang, A., Scorilas, A., and Diamandis, E.P. (2000a). Genomic organization of the human kallikrein gene family on chromosome 19q13.3–q13.4. Biochem. Biophys. Res. Commun.276, 125–133.10.1006/bbrc.2000.3448Search in Google Scholar PubMed
Yousef, G.M., Magklara, A., and Diamandis, E.P. (2000b). KLK12 is a novel serine protease and a new member of the human kallikrein gene family – differential expression in breast cancer. Genomics69, 331–341.10.1006/geno.2000.6346Search in Google Scholar PubMed
©2007 by Walter de Gruyter Berlin New York
